Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05892718
Title A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPa-CD47 Pathway, in Solid or Hematological Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors FBD Biologics Limited
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.